351 related articles for article (PubMed ID: 34177417)
1. Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.
Körper S; Jahrsdörfer B; Corman VM; Pilch J; Wuchter P; Blasczyk R; Müller R; Tonn T; Bakchoul T; Schäfer R; Juhl D; Schwarz T; Gödecke N; Burkhardt T; Schmidt M; Appl T; Eichler H; Klüter H; Drosten C; Seifried E; Schrezenmeier H
Transfus Med Hemother; 2021 May; 48(3):137-147. PubMed ID: 34177417
[TBL] [Abstract][Full Text] [Related]
2. Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.
Annen K; Morrison TE; DomBourian MG; McCarthy MK; Huey L; Merkel PA; Andersen G; Schwartz E; Knight V
Transfusion; 2021 Apr; 61(4):1148-1159. PubMed ID: 33452828
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
[TBL] [Abstract][Full Text] [Related]
4. Anti-SARS-CoV-2 Serology persistence over time in COVID-19 Convalescent Plasma Donors.
De Giorgi V; West KA; Henning AN; Chen L; Holbrook MR; Gross R; Liang J; Postnikova E; Trenbeath J; Pogue S; Scinto T; Alter HJ; Cantilena CC
medRxiv; 2021 Mar; ():. PubMed ID: 33758897
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study.
Ravula U; Chunchu SR; Mooli S; Naik R; Sarangapati PRR
Transfus Clin Biol; 2022 May; 29(2):107-111. PubMed ID: 35167958
[TBL] [Abstract][Full Text] [Related]
6. Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies.
Jazbec K; Jež M; Žiberna K; Mali P; Ramšak Ž; Potokar UR; Kvrzić Z; Černilec M; Gracar M; Šprohar M; Jovanovič P; Vuletić S; Rožman P
Virol J; 2023 Mar; 20(1):53. PubMed ID: 36973781
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.
Volk A; Covini-Souris C; Kuehnel D; De Mey C; Römisch J; Schmidt T
BioDrugs; 2022 Jan; 36(1):41-53. PubMed ID: 34843105
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates.
Uzun G; Müller R; Althaus K; Becker M; Marsall P; Junker D; Nowak-Harnau S; Schneiderhan-Marra N; Klüter H; Schrezenmeier H; Bugert P; Bakchoul T
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376656
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections.
Wendel S; Fontão-Wendel R; Fachini R; Candelaria G; Scuracchio P; Achkar R; Brito M; Reis LF; Camargo A; Amano M; Machado R; Araujo D; Soares C; Durigon E
Transfusion; 2021 May; 61(5):1447-1460. PubMed ID: 33604884
[TBL] [Abstract][Full Text] [Related]
10. Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations.
Hayes C; Rubenstein W; Gibb D; Klapper E; Tanaka J; Pepkowitz S
Transfusion; 2021 Aug; 61(8):2245-2249. PubMed ID: 34036595
[TBL] [Abstract][Full Text] [Related]
11. The predictors of high titer of
Wardhani SO; Fajar JK; Nurarifah N; Hermanto DH; Fatonah S; Djajalaksana S; Fatoni AZ; Arsana PM; Wulandari L; Soegiarto G; Dhama K; Harapan H
Clin Epidemiol Glob Health; 2021; 11():100763. PubMed ID: 33997476
[TBL] [Abstract][Full Text] [Related]
12. A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma.
Wouters E; Verbrugghe C; Devloo R; Debruyne I; De Clippel D; Van Heddegem L; Van Asch K; Van Gaver V; Vanbrabant M; Muylaert A; Compernolle V; Feys HB
Transfusion; 2021 Oct; 61(10):2981-2990. PubMed ID: 34498761
[TBL] [Abstract][Full Text] [Related]
13. Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China.
Tang J; Liu H; Wang Q; Gu X; Wang J; Li W; Luo Y; Li Y; Deng L; Luo Y; Du X; Tan D; Fu X; Chen X
Front Immunol; 2023; 14():1191479. PubMed ID: 37388736
[TBL] [Abstract][Full Text] [Related]
14. Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion.
Wirz OF; Röltgen K; Stevens BA; Pandey S; Sahoo MK; Tolentino L; Verghese M; Nguyen K; Hunter M; Snow TT; Singh AR; Blish CA; Cochran JR; Zehnder JL; Nadeau KC; Pinsky BA; Pham TD; Boyd SD
Front Immunol; 2021; 12():739037. PubMed ID: 34594341
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 52 240 source plasma donors of convalescent COVID-19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation.
Schmidt AE; Vogel P; Chastain CA; Barnes T; Roth NJ; Simon TL
J Clin Apher; 2022 Oct; 37(5):449-459. PubMed ID: 35815776
[TBL] [Abstract][Full Text] [Related]
16. Utility of COVID-19 Seropositive Plasma as Convalescent Plasma: An Immune and Neutralization Antibody Seroprevalence Analysis in Blood Donors for Future Potential Pandemic Readiness.
Jain A; Negi G; Kaur D; S V; Saxena V
Cureus; 2024 Mar; 16(3):e57149. PubMed ID: 38681329
[TBL] [Abstract][Full Text] [Related]
17. Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma.
Girardin RC; Dupuis AP; Payne AF; Sullivan TJ; Strauss D; Parker MM; McDonough KA
J Infect Dis; 2021 Mar; 223(5):743-751. PubMed ID: 33417696
[TBL] [Abstract][Full Text] [Related]
18. How we secured a COVID-19 convalescent plasma procurement scheme in Japan.
Terada M; Kutsuna S; Togano T; Saito S; Kinoshita N; Shimanishi Y; Suzuki T; Miyazato Y; Inada M; Nakamoto T; Nomoto H; Ide S; Sato M; Maeda K; Matsunaga A; Satake M; Matsubayashi K; Tsuno H; Kojima M; Kuramistu M; Tezuka K; Ikebe E; Okuma K; Hamaguchi I; Shiratori K; Sato M; Kawakami Y; Inaba K; Igarashi S; Yamauchi R; Matsumura M; Ishimaru K; Zhang B; Kuge C; Ishihara M; Gouda M; Tanaka K; Ishizaka Y; Ohmagari N
Transfusion; 2021 Jul; 61(7):1998-2007. PubMed ID: 34096059
[TBL] [Abstract][Full Text] [Related]
19. Absence of correlation between ABO Rh(D) blood group and neutralizing antibody titers in SARS-CoV-2 convalescent plasma donors.
Hirani R; Hoad V; Gosbell IB; Irving DO
Transfusion; 2022 Feb; 62(2):292-297. PubMed ID: 34936102
[TBL] [Abstract][Full Text] [Related]
20. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
